NEWAMSTERDAM PHARMA COMPANY

Ticker: NAMS CUSIP: N62509109 Class: Stock

RA CAPITAL MANAGEMENT, L.P.'s Holding History (CIK: 0001346824)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 9,550,191 Value ($000) $335,021 Avg Close $36.39 Range $28.19 - $42.00
Q3 2025
Shares 10,138,938 Value ($000) $288,351 Avg Close $23.97 Range $17.97 - $28.91
Q2 2025
Shares 10,138,938 Value ($000) $183,616 Avg Close $18.24 Range $14.06 - $22.25
Q1 2025
Shares 10,138,938 Value ($000) $207,544 Avg Close $22.23 Range $17.18 - $26.80
Q4 2024
Shares 8,845,000 Value ($000) $227,317 Avg Close $21.24 Range $15.51 - $27.29
Q3 2024
Shares 8,064,000 Value ($000) $133,862 Avg Close $17.30 Range $15.19 - $21.48
Q2 2024
Shares 8,064,000 Value ($000) $154,909 Avg Close $20.06 Range $16.62 - $24.79
Q1 2024
Shares 7,864,000 Value ($000) $185,984 Avg Close $20.30 Range $11.18 - $26.35
Q4 2023
Shares 7,864,000 Value ($000) $87,841 Avg Close $9.16 Range $5.63 - $11.89
Q3 2023
Shares 9,000,000 Value ($000) $83,250 Avg Close $10.83 Range $8.57 - $12.54
Q2 2023
Shares 9,000,000 Value ($000) $107,010 Avg Close $13.27 Range $11.03 - $17.00
Q1 2023
Shares 4,000,000 Value ($000) $53,040 Avg Close $12.62 Range $9.50 - $18.70
Q4 2022
Shares 4,000,000 Value ($000) $43,600 Avg Close $9.95 Range $7.52 - $32.88